ClinicalTrials.gov
public full text
Public Domain
STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS
A phase1 study to evaluate the PK (single dose and multiple doses) and safety of talazoparib 1 mg Once Daily in Chinese adult participants with advanced solid tumors. A maximum of approximately 15 participants will be enrolled such that approximately 12 evaluable participants complete the study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers#844793
- Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors#902052
- CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas#850435
- Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors#1126531
- Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia#992957
Record · ID 1139660
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive